CBIZ (CBZ) Stock Looks Fairly Priced Following The $5 Billion Cash Deal

CBIZ, Inc.

CBIZ, Inc.

CBZ

0.00

CBIZ stock has surged in recent weeks and now trades very close to the US$55 per share price implied in Grant Thornton Advisors' agreed all cash acquisition, while the company's broader valuation checks still suggest the shares lean cheap rather than stretched.

  • Over the past 5 years CBIZ has delivered a total return of about 70%, which points to meaningful long term value creation for shareholders compared to shorter term swings.
  • The proposed US$5b all cash takeover by Grant Thornton Advisors can anchor expectations for CBIZ's worth. Execution risk around closing the deal and separating the benefits and insurance business may still influence how investors think about fair value.
  • CBIZ scores highly on Simply Wall St's valuation checks, with 5 out of 6 metrics suggesting the stock screens as relatively inexpensive on the fundamentals tested.

The issue now is whether the current price near the agreed takeover level still offers enough upside for investors who are weighing CBIZ on valuation grounds versus deal risk and alternative opportunities.

Where Does CBIZ Sit on Earnings?

The P/E ratio suits CBIZ because earnings are a central anchor for investors in professional services stocks. CBIZ currently trades on about 18.5x earnings, which sits below the Professional Services industry average of roughly 21.8x and also below the peer group average of about 28.9x. The Fair Ratio model, which looks at factors such as growth, profitability, sector and size, points to a P/E of around 19.0x for CBIZ.

That means CBIZ is only slightly under this tailored fair value mark, even with the Grant Thornton deal helping to focus attention on the business. The current P/E gap to the Fair Ratio is modest compared with the gap to the simple industry and peer averages. As a result, the multiple suggests the stock is broadly lining up with what the fundamentals would justify on this framework.

On the P/E multiple, CBIZ stock looks priced at roughly fair value rather than clearly cheap or expensive.

NYSE:CBZ P/E Ratio as at Jul 2026
NYSE:CBZ P/E Ratio as at Jul 2026

The CBIZ Narrative: What Would Justify Today's Price?

Simply Wall St Narratives for CBIZ pick up where the P/E puzzle leaves off and explain what patterns in future growth, margins and earnings would need to hold for CBIZ's stock to be worth meaningfully more or less than it is today. Each narrative links its numbers to a clear view on potential changes in CBIZ's growth, profitability and risk profile, which gives you a reference point to revisit as fresh information becomes available.

One of the top community narratives on CBIZ: 31% overvalued

"A meaningful part of revenue depends on nonrecurring, project based advisory and M&A related work that is sensitive to deal cycles and client confidence..."

Do you think there's more to the story for CBIZ? Head over to our Community to see what others are saying!

The Bottom Line

CBIZ now looks roughly in line with what its P/E and tailored Fair Ratio suggest, rather than clearly undervalued or overvalued. The stronger valuation checks still point to support from fundamentals, even though the headline multiple sits close to a fair value zone. From here, what matters most is whether CBIZ can sustain the earnings profile that underpins that P/E while the Grant Thornton deal progresses, and any transaction risk around closing and business separation remains in focus.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.